SG11202004891PA - Novel use of 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative - Google Patents

Novel use of 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative

Info

Publication number
SG11202004891PA
SG11202004891PA SG11202004891PA SG11202004891PA SG11202004891PA SG 11202004891P A SG11202004891P A SG 11202004891PA SG 11202004891P A SG11202004891P A SG 11202004891PA SG 11202004891P A SG11202004891P A SG 11202004891PA SG 11202004891P A SG11202004891P A SG 11202004891PA
Authority
SG
Singapore
Prior art keywords
benzyloxy
hex
phenyl
acid derivative
novel use
Prior art date
Application number
SG11202004891PA
Inventor
Dae Hoon Kim
Chun Hwa Kim
Sun Hee Lee
Goeun Yang
Seung Jun Kang
Hyo Sun Choi
Original Assignee
Hyundai Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyundai Pharm Co Ltd filed Critical Hyundai Pharm Co Ltd
Publication of SG11202004891PA publication Critical patent/SG11202004891PA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/02—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 2
    • C07D317/06—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 2 condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11202004891PA 2017-12-01 2018-12-03 Novel use of 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative SG11202004891PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762593350P 2017-12-01 2017-12-01
PCT/KR2018/015201 WO2019108046A1 (en) 2017-12-01 2018-12-03 Novel use of 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative

Publications (1)

Publication Number Publication Date
SG11202004891PA true SG11202004891PA (en) 2020-06-29

Family

ID=66665761

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202004891PA SG11202004891PA (en) 2017-12-01 2018-12-03 Novel use of 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative

Country Status (4)

Country Link
KR (1) KR102090079B1 (en)
SG (1) SG11202004891PA (en)
WO (1) WO2019108046A1 (en)
ZA (1) ZA202003028B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102270026B1 (en) * 2020-01-31 2021-06-28 현대약품 주식회사 Quality evaluation method of (3S)-3-(4-(3-(1,4-dioxaspiro[4,5]dec-7-en-8-yl)benzyloxy)phenyl)hex-4-ynoic acid
KR20220136800A (en) * 2021-04-01 2022-10-11 현대약품 주식회사 Novel use of 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100354912B1 (en) * 2000-06-21 2002-10-05 박병현 Antidiabetic Amomum xanthoides extract and composition containing the extract as effective ingredient
KR20100104482A (en) * 2009-03-18 2010-09-29 한림대학교 산학협력단 Puple corn anthocyanins with excellent blood glucose control activity and efficient protective activity for diabetic loss of pancreatic beta cells
KR101121954B1 (en) * 2010-05-13 2012-03-09 아주대학교산학협력단 Composition for preventing or treating diabetes comprising 1,2,3-Benzentricarboxylic acid
RU2627703C2 (en) * 2010-07-23 2017-08-10 Конекшис Лайф Сайенсиз Пвт. Лтд. Gpr40 agonists
KR20140097837A (en) * 2013-01-30 2014-08-07 부산대학교 산학협력단 PADINA ARBORESCENS EXTRACT FOR PROMOTING INSULIN SECRETION AND PROTECTING PANCREATIC β CELL
KR101569522B1 (en) * 2013-04-18 2015-11-17 현대약품 주식회사 Novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative, preparation method thereof, and pharmaceutical composition for use in preventing or treating metabolic diseases containing the same as an active ingredient
DK3207928T3 (en) * 2014-10-17 2021-04-26 Hyundai Pharm Co Ltd Composite composition containing novel 3- (4- (benzyloxy) phenyl) hex-4-inonic acid derivative and another active ingredient, for the prevention or treatment of metabolic diseases

Also Published As

Publication number Publication date
WO2019108046A1 (en) 2019-06-06
KR20190141007A (en) 2019-12-20
ZA202003028B (en) 2021-08-25
KR102090079B1 (en) 2020-03-17

Similar Documents

Publication Publication Date Title
PH12017500361B1 (en) Novel compounds
IL266214B (en) 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh
IL274488B1 (en) Crystalline forms of n-(4-(4-(cyclopropylmethyl) piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide
IL250255B (en) Substituted phenyl alkanoic acid compounds as gpr120 agonists and uses thereof
HK1247201A1 (en) Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
DK2987791T3 (en) 3- (4- (Benzyloxy) phenyl) hex-4-acid acid derivative, suitable for the prevention and treatment of metabolic disorders
SI3464265T1 (en) Polymorphs of n-((3-fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-((4-(2-oxopyridin-1-yl)methyl)phenyl)methyl)pyrazole-4-carboxamide as kallikrein inhibitors
SG11201600996UA (en) Formulations of (s)-3-(4-((4-(morpholinomethyl)benzyloxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
DK3207928T3 (en) Composite composition containing novel 3- (4- (benzyloxy) phenyl) hex-4-inonic acid derivative and another active ingredient, for the prevention or treatment of metabolic diseases
PL3464276T3 (en) New crystalline form of n-[5-(3,5-difluoro-benzyl)-1h-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydropyran-4-ylamino)-benzamide
PH12016501941A1 (en) Use of heterocyclic compounds for controlling nematodes
MX2018007219A (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds.
TW201613934A (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
ZA201701132B (en) Novel 2,5-substituted pyrimidines as pde inhibitors
ZA202003028B (en) Novel use of 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative
HUE044642T2 (en) Process for the production of 2-[4-(cyclopropanecarbonyl)phenyl]-2-methyl-propanenitrile
SG11202105114PA (en) Storage-stable form of 3-methylthiopropionaldehyde